Cultivated meat — grown from animal cells in bioreactors rather than from slaughtered animals — promises to dramatically reduce farm animal suffering, but welfare questions surround cell donor animals and production processes.
The welfare promise of cultivated meat is compelling: if it achieves scale, billions of farm animals could be spared the conditions of intensive agriculture. However, current production involves welfare concerns that must be addressed. Fetal bovine serum collection involves slaughtering pregnant cows and extracting serum from fetuses — a significant welfare harm. Development of serum-free media is advancing but not yet fully solved at commercial scale. Donor animals from which cell lines are established require welfare-appropriate housing. The long-term vision of cell banking from minimal animals with no ongoing slaughter represents a genuine welfare improvement, but the transition pathway matters morally. Consumer adoption rates and regulatory environments will determine how quickly and completely cultivated meat can achieve its welfare potential.